Under Trump, FDA seeks to abandon expert reviews of new drugs
- Posted on September 14, 2025
- By San Francisco Chronicle
- 4 Views
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA leaders under President Trump may drop a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny.
